M.D. Anderson Cancer Center
The goal of this research study is to measure changes in patients' quality of life after surgeries that affect the facial nerve, including nerve transfer as treatment for facial paralysis.
Cancer
Head and Neck Cancer
Nerve transfer techniques
NA
Primary Objective: To evaluate the impact of facial nerve transfer techniques (FNTT) on QoL in head and neck cancer patients with facial paralysis. This study intends to measure the impact of FNTT on QoL utilizing a series of validated questionnaires which include: (i) Facial Clinimetric Evaluation Scale and Facial Disability Index; (ii) Sunnybrook Facial Grading System; and (iii) Facial Nerve Grading Scale 2.0. These instruments will be administered at baseline, after surgery, and at 6, 12, and 18 months post-operatively. Secondary Objective: To compare patient-reported outcomes and facial function scales for patients who undergo facial nerve transfer technique with a historical cohort of patients who did not undergo any dynamic nerve reconstruction procedures. The same assessment tools described in primary objective above will be utilized.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 40 participants |
Masking : | NONE |
Primary Purpose : | SUPPORTIVE_CARE |
Official Title : | Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life |
Actual Study Start Date : | 2025-04-01 |
Estimated Primary Completion Date : | 2026-08-01 |
Estimated Study Completion Date : | 2028-08-01 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States, 77030